Alphatec Holdings, Inc. (ATEC)
| Market Cap | 1.45B |
| Revenue (ttm) | 764.16M |
| Net Income (ttm) | -143.36M |
| Shares Out | 151.36M |
| EPS (ttm) | -0.96 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,214,046 |
| Open | 10.38 |
| Previous Close | 10.36 |
| Day's Range | 9.54 - 10.56 |
| 52-Week Range | 9.53 - 23.29 |
| Beta | 1.12 |
| Analysts | Strong Buy |
| Price Target | 22.00 (+130.37%) |
| Earnings Date | May 5, 2026 |
About ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-o... [Read more]
Financial Performance
In 2025, Alphatec Holdings's revenue was $764.16 million, an increase of 24.95% compared to the previous year's $611.56 million. Losses were -$143.36 million, -11.57% less than in 2024.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for ATEC stock is "Strong Buy." The 12-month stock price target is $22.0, which is an increase of 130.37% from the latest price.
News
ATEC to Report First Quarter 2026 Financial Results on May 5, 2026
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will r...
Alphatec Holdings Transcript: Barclays 28th Annual Global Healthcare Conference
Strong growth and profitability were achieved through clinical distinction, surgeon adoption, and share gains amid industry disruption. Enabling technologies like the Valence robot support procedural integration, while disciplined capital deployment and efficient sales force expansion underpin continued confidence in future growth.
Alphatec Holdings Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 saw 20% and 25% revenue growth, respectively, with strong margin expansion and positive free cash flow. 2026 guidance was raised for both revenue and Adjusted EBITDA, driven by innovation, surgeon adoption, and operational leverage.
ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced ...
Alphatec Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference
Consistent execution and innovation have driven strong growth, with 2025 revenue at $764 million and a target of $890 million for 2026. Investments in informatics and procedural integration, along with international expansion and robust profitability, position the company for continued success.
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDE...
ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today ...
Alphatec Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference
Lateral spine procedures and robotics are driving strong growth, with significant market expansion potential through technology integration and sales force development. Informatics and automation are set to further differentiate offerings, while disciplined investment supports self-funded growth.
ATEC Mourns Passing of Board Member Jeffrey P. Rydin
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with ...
Top 2 Health Care Stocks That May Fall Off A Cliff This Quarter
As of Oct. 31, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Alphatec Holdings Earnings Call Transcript: Q3 2025
Q3 revenue grew 30% year-over-year to $197 million, with adjusted EBITDA at $26 million and strong free cash flow. Full-year guidance was raised to $760 million, driven by robust adoption in surgical and EOS segments, and the company remains on track for its 2027 financial targets.
ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced ...
ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will r...
Alphatec Holdings Transcript: Wells Fargo 20th Annual Healthcare Conference 2025
Sustained revenue growth and profitability are driving positive cash flow, with 21% top-line growth expected in 2024 and continued investments in innovation, notably the Valence robot launch. International expansion remains focused, and the lateral portfolio is the main growth driver.
ATEC to Participate in Upcoming Conferences
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that managemen...
Alphatec Holdings Earnings Call Transcript: Q2 2025
Q2 2025 delivered 27% revenue growth and record adjusted EBITDA, with strong same-store sales and surgeon adoption. Full-year guidance was raised for both revenue and EBITDA, and positive free cash flow is expected to continue.
ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced ...
ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will r...
Alphatec Holdings Earnings Call Transcript: Q1 2025
Q1 2025 delivered 22% revenue growth and record surgical adoption, with adjusted EBITDA up over 800 bps year-over-year. Guidance for 2025 was raised, with strong cash flow and margin expansion expected, while new product launches and international growth continue to drive momentum.
ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial resu...
ATEC Launches PTP™ Corpectomy, The Next Evolution of Lateral Approach Surgery
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial...
Alphatec Holdings Transcript: Barclays 27th Annual Global Healthcare Conference
A recent $405 million refinancing extended debt maturities to 2030, supporting strong 20% revenue growth projections for 2025, driven by lateral franchise expansion, new product launches, and international growth. Margin expansion and positive cash flow are expected, with operational leverage and a growing sales force supporting future performance.
ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of...
ATEC Announces Proposed Convertible Senior Notes Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced its intention ...
Alphatec Holdings Earnings Call Transcript: Q4 2024
Q4 2024 saw 28% revenue growth and strong profitability, with full-year revenue up 27% to $612 million and Adjusted EBITDA of $31 million. 2025 guidance projects 20% revenue growth, $75 million Adjusted EBITDA, and positive cash flow, driven by continued innovation and market expansion.